Skip to content

Masimo W1

by Masimo Corporation 3 variants

510(k) K240229

Active United States

510(k)

Valid until

No expiry

510(k) clearance is not time-limited

FDA recalls

None found

in data synced 22 Oct 2026

Documents

Trust

Unverified

Source FDA 510(k), synced 22 Oct 2026.

Regulatory status

as of registry sync 22 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE Substantially Equivalent · Traditional NumberK240229 Date8 Aug 2024ClearedStatusActive

Official records

From the FDA record

Received by the FDA
29 Jan 2024
FDA decision
8 Aug 2024 (Substantially Equivalent)
FDA review time
192 days from receipt to decision
Public document
510(k) summary on file with the FDA

From the FDA 510(k) record K240229 (openFDA), as read on 22 Oct 2026. Quoted as published, gaps included; nothing on this list is generated.

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Specification

510(k)

510(k) Number
FDA product code
DPS
Device class
Class II
Regulation
21 CFR Part 870.2340
Advisory committee
Cardiovascular
FDA decision
SESE Substantially Equivalent

Overview

AI-generated summary, 24 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

The Masimo W1 is a medical device designed for cardiovascular monitoring. It functions to track physiological data to assist in clinical assessment.

This device is authorized via FDA 510k clearance under the traditional pathway. It is identified by the product code DPS and is manufactured by Masimo Corporation.

Similar devices

Other devices filed under FDA product code DPS (Electrocardiograph).

Other devices from Masimo Corporation

See all devices from Masimo Corporation →